“the-university-of-texas-md-anderson-cancer-center” Archives

in
Entry Author Date Location
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M 11/29/17 Boston
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial 06/21/16 National
West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More 11/06/15 San Francisco
With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal 10/01/15 Boston
Premier Boosts Health IT Capabilities with $400M CECity Acquisition 08/04/15 Raleigh Durham
West Coast Biotech Roundup: Regulus, Ardelyx, Juno, Sangamo & More 06/04/15 San Francisco
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug 12/07/14 San Francisco
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
What Price Technology? At NYT Health Confab, It’s a Loaded Question 05/30/14 San Francisco
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Page 1 of 1